美国战略国家储备呼吸机在COVID-19中的功能比较及20万台紧急采购分析
该研究由多学科灾害专家团队通过综述已发表文献、公开文件和媒体报道,评估COVID-19患者对呼吸机的需求,并比较美国战略国家储备(SNS)呼吸机及新订购的20万台设备的功能。结果显示,COVID-19患者常出现严重低氧性急性呼吸衰竭和ARDS,需要高水平呼吸机支持;现有SNS呼吸机无法完全支持所有COVID-19患者,仅约半数新订购呼吸机具备支持最重症患者的能力,但支持能力较低的呼吸机对许多患者仍有重要价值。研究还总结了当前SNS呼吸机遇到的技术、后勤和教育挑战,并提出了下一代SNS呼吸机的潜在更新建议。
要点
- COVID-19患者常发生严重低氧性急性呼吸衰竭和ARDS,需要高水平呼吸机支持。
- 现有SNS呼吸机无法完全支持所有COVID-19患者。
- 新订购的20万台呼吸机中仅约半数具备支持最重症患者的能力。
- 支持能力较低的呼吸机对许多患者仍有重要价值。
- 当前SNS呼吸机存在技术、后勤和教育方面的挑战。
适用人群与场景
- 受COVID-19影响需要机械通气的患者。
研究设计与关键结果
- 研究类型为综述与专家分析,无样本量及中心数报告;通过回顾已发表文献、公开文件和媒体报道,评估COVID-19患者呼吸机需求并比较SNS呼吸机功能。
- COVID-19患者常出现严重低氧性急性呼吸衰竭和ARDS,需要高水平呼吸机支持。
- 现有SNS呼吸机无法完全支持所有COVID-19患者。
- 新订购的呼吸机中仅约半数具备支持最重症患者的能力;支持能力较低的呼吸机对许多患者仍有重要价值。
证据类型、等级与局限
- 证据类型为综述与专家分析;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,现有及新订购的SNS呼吸机可支持大多数但非全部COVID-19患者。
- 作者总结了当前SNS呼吸机遇到的技术、后勤和教育挑战,并提出了下一代SNS呼吸机的潜在更新建议。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early in the coronavirus disease 2019 (COVID-19) pandemic, there was serious concern that the United States would encounter a shortfall of mechanical ventilators. In response, the US government, using the Defense Production Act, ordered the development of 200,000 ventilators from 11 different manufacturers. These ventilators have different capabilities, and whether all are able to support COVID-19 patients is not evident.
RESEARCH QUESTION: Evaluate ventilator requirements for affected COVID-19 patients, assess the clinical performance of current US Strategic National Stockpile (SNS) ventilators employed during the pandemic, and finally, compare ordered ventilators' functionality based on COVID-19 patient needs.
STUDY DESIGN AND METHODS: Current published literature, publicly available documents, and lay press articles were reviewed by a diverse team of disaster experts. Data were assembled into tabular format, which formed the basis for analysis and future recommendations.
RESULTS: COVID-19 patients often develop severe hypoxemic acute respiratory failure and adult respiratory defense syndrome (ARDS), requiring high levels of ventilator support. Current SNS ventilators were unable to fully support all COVID-19 patients, and only approximately half of newly ordered ventilators have the capacity to support the most severely affected patients; ventilators with less capacity for providing high-level support are still of significant value in caring for many patients.
INTERPRETATION: Current SNS ventilators and those on order are capable of supporting most but not all COVID-19 patients. Technologic, logistic, and educational challenges encountered from current SNS ventilators are summarized, with potential next-generation SNS ventilator updates offered.
参考来源
- Branson R, Dichter JR, Feldman H, et al. The US Strategic National Stockpile Ventilators in Coronavirus Disease 2019: A Comparison of Functionality and Analysis Regarding the Emergency Purchase of 200,000 Devices. Chest. 2020. PMID: 32971074. doi:10.1016/j.chest.2020.09.085
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。